Mesenchymal
stromal (stem) cells have potential in regenerative medicine and modulating
the immune system. To deliver any cell-based therapy to the patient,
it must be cryopreserved, most commonly in DMSO, which impacts cell
function and causes clinical side effects. Here we report the use
of a synthetically scalable polyampholyte to rescue the cryopreservation
of mesenchymal stromal cells in low [DMSO] cryopreservation. Flow
cytometry showed retention of key markers of multipotency comparable
to 10% (v/v) DMSO, and the cells could be differentiated, showing
this polymer material can be used to improve, or replace, current
cryopreservation strategies.